AIM Immunotech Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AIM Immunotech Inc. on April 19, 2021. The report details the completion of an asset disposition at the Company's facility located at 783 Jersey Ave., New Brunswick, N.J.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figure disclosed is the aggregate sale price of $245,500 for obsolete equipment and machinery.
Material Changes
- Asset Disposition: The Company signed an agreement to sell obsolete equipment and machinery no longer needed for current or future manufacturing.
- Transaction Value: The assets are being sold to Phoenix Equipment Corporation, Branford Auctions, LLC, and Perry Videx LLC for a total of $245,500.
- Timing: The sale is anticipated to be completed by the end of the week following the report date.
- Related Event: This sale is in conjunction with the Company's exercise of its option to repurchase the New Brunswick facility, as previously reported in an 8-K filed on April 9, 2021.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the operational context of divesting obsolete assets. No unusual items or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the closing date of the asset sale to confirm the receipt of the $245,500 proceeds.
- Review the April 9, 2021 Form 8-K to understand the terms and financial impact of the facility repurchase option.
- Confirm the impact of this asset sale on the Company's balance sheet and cash position in subsequent quarterly filings.